A Phase IV Multicentre, Randomised, Double-Blind, Placebo Controlled, Trial to Evaluate the Safety and Efficacy of Raptiva in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis Involving Hands and/or Feet, With or Without Pustules.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2014
At a glance
- Drugs Efalizumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms TRUST
- Sponsors Merck Serono
- 28 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database.
- 13 Oct 2009 New trial record.